Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly carboplatin chemoradiotherapy for cisplatin-ineligible head and neck squamous cell carcinoma
jRCTs031190028Phase 2Completed
- Start
- Jun 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin in head and neck squamous cell carcinoma (HNSCC). Primary endpoint: Completion rate of chemoradiotherapy. Started Jun 2019; status: completed.
02
Drugs
carboplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on jRCTs031190028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190028.